Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea
- 28 February 2005
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 6 (2), 93-102
- https://doi.org/10.1016/s1470-2045(05)01735-3
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Palonosetron: a unique 5-HT3-receptor antagonist for the prevention of chemotherapy-induced emesisExpert Opinion on Pharmacotherapy, 2003
- Thymidine Rescue: An Antidote for Pemetrexed-Related Toxicity in the Setting of Acute Renal FailureJournal of Clinical Oncology, 2003
- Prevention of cisplatin‐induced acute and delayed emesis by the selective neurokinin‐1 antagonists, L‐758,298 and MK‐869Cancer, 2002
- Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF: results of a prospective randomised trialEuropean Journal Of Cancer, 2001
- Disposition and metabolism of the flavonoid chrysin in normal volunteersBritish Journal of Clinical Pharmacology, 2001
- Antiemetic Study Methodology: Recommendations for Future StudiesOncology, 1996
- Protective Effects of Kampo Medicines and Baicalin against Intestinal Toxicity of a New Anticancer Camptothecin Derivative, Irinotecan Hydrochloride (CPT‐11), in RatsJapanese Journal of Cancer Research, 1995
- A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analoguesEuropean Journal of Cancer and Clinical Oncology, 1988
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983
- Emesis as a Critical Problem in ChemotherapyNew England Journal of Medicine, 1981